5-Amino-1MQ Guide: Dosage, Fat Loss Mechanism & NNMT Explained
5-Amino-1MQ
5-Amino-1MQ is a small-molecule compound studied for fat metabolism, body composition, and cellular energy regulation. It works by inhibiting NNMT (nicotinamide N-methyltransferase), a pathway linked to obesity and metabolic dysfunction.
How It Works
NNMT Inhibition ↓ → NAD+ Availability ↑ → Energy Metabolism ↑ → Fat Storage ↓
5-Amino-1MQ inhibits NNMT, an enzyme associated with fat accumulation and metabolic inefficiency. By reducing NNMT activity, it may improve cellular energy utilization and shift the body toward increased fat metabolism.
Important Distinction
5-Amino-1MQ is not a peptide.
It is a small-molecule metabolic regulator.
It works through NNMT inhibition, not hormone signaling pathways.
Injectable 5-Amino-1MQ Reconstitution & Dosing
Injectable 5-Amino-1MQ → BAC Water → SubQ Research Use → Lower mg Range Than Oral
Important distinction:
5-Amino-1MQ is still most commonly discussed as an oral compound, but injectable research vials do exist. Injectable dosing should not be directly compared to oral dosing because the route changes exposure and practical dose ranges.
5-Amino-1MQ is still most commonly discussed as an oral compound, but injectable research vials do exist. Injectable dosing should not be directly compared to oral dosing because the route changes exposure and practical dose ranges.
Common Injectable Vial Sizes
Smaller Vial10 mg
Larger Vial50 mg
The 50 mg vial is usually more practical for multi-day use because injectable doses are commonly discussed in the low-mg range.
10 mg Vial Option
Vial10 mg
BAC Water2.0 mL
Concentration5 mg/mL
Conversion1 unit = 50 mcg
Dose Reference
50 units = 2.5 mg
100 units = 5 mg
At 5 mg daily, a 10 mg vial lasts about 2 days
At 2.5 mg daily, a 10 mg vial lasts about 4 days
50 mg Vial Option
Vial50 mg
BAC Water4.0 mL
Concentration12.5 mg/mL
Conversion1 unit = 125 mcg
Dose Reference
20 units = 2.5 mg
40 units = 5 mg
At 5 mg daily, a 50 mg vial lasts about 10 days
At 2.5 mg daily, a 50 mg vial lasts about 20 days
Most Common Injectable Dose Range
Tolerance Dose2.5 mg once daily
Standard Dose5 mg once daily
Split Option2.5 mg twice daily
RouteSubcutaneous
Reconstitution Steps
Draw the correct amount of bacteriostatic water for the vial size
Inject slowly down the vial wall
Gently swirl, do not shake
Allow the compound to fully dissolve before use
Refrigerate after reconstitution
Simple takeaway:
Injectable 5-Amino-1MQ is usually discussed in the 2.5–5 mg daily range. A 10 mg vial works for short testing, while a 50 mg vial is more practical for a longer injectable research cycle.
Injectable 5-Amino-1MQ is usually discussed in the 2.5–5 mg daily range. A 10 mg vial works for short testing, while a 50 mg vial is more practical for a longer injectable research cycle.
5-Amino-1MQ Protocol
NNMT Inhibition → NAD+ Pathway Support → Metabolic Efficiency → Fat Metabolism Support
Oral Approach (Most Common)
Low Dose50 mg daily
Standard100 mg daily
Advanced150 mg daily
Split Dosing Option
50 mg AM + 50 mg PM
Low Dose
Starting Range
Dose50 mg daily
RouteOral
FrequencyOnce daily
Standard Range
Common Range
Dose100 mg daily
RouteOral
FrequencyOnce daily or split dosing
Advanced Range
Higher Range
Dose150 mg daily
RouteOral
FrequencyUsually split if needed
Simple approach:
5-Amino-1MQ is usually approached as a metabolic-support compound rather than a stimulant. Starting lower makes it easier to assess energy, appetite, and body-composition response before moving higher.
5-Amino-1MQ is usually approached as a metabolic-support compound rather than a stimulant. Starting lower makes it easier to assess energy, appetite, and body-composition response before moving higher.
How to Use 5-Amino-1MQ (Cycle, Timing & Structure)
Frequency1–2x daily
RouteOral (most common)
Cycle Length4–8 weeks
Common TimingMorning or early afternoon
FoodCan be taken with or without food
Best Time to Take
Morning or early afternoon is usually preferred.
It can be taken with or without food.
Split dosing may improve consistency for some people.
Avoid late dosing if sensitive or if it affects sleep.
When to Use
During fat-loss phases
During metabolic-support phases
When body composition and energy metabolism are the main goals
As part of a structured plan rather than casual nonstop use
Simple Strategy
Use in Phases
5-Amino-1MQ is usually best framed as a metabolic-support phase, not a quick stimulant or appetite-suppressant tool.
Goal-Based Use
Pair it with calorie control, training, and a clear body-composition goal, then reassess after the cycle.
Alternative Delivery (Research Context)
Alternative Delivery Notes
Injectable versions exist in research settings
Oral administration is most commonly used
Dosing differs significantly between formats
Simple takeaway:
Most public discussion around 5-Amino-1MQ centers on oral use. Injectable versions should not be converted directly using oral dose assumptions because delivery method changes exposure and dosing context.
Most public discussion around 5-Amino-1MQ centers on oral use. Injectable versions should not be converted directly using oral dose assumptions because delivery method changes exposure and dosing context.
Real-World vs Clinical Use
Real-World Use
Typical Range50–100 mg daily
GoalFat loss + metabolic support
Clinical / Research Context
FocusNNMT inhibition + metabolic regulation
MechanismNAD+ pathway support
Time Between Cycles
Metabolic Support Phase → Reset → Reassess → Repeat if Needed
Standard Time Between Cycles
Cycle Length4–8 weeks
Time Off2–4 weeks
Why take a break?
5-Amino-1MQ is typically used as a metabolic-support compound. Taking time off after a focused cycle helps you reassess body-composition response, appetite changes, energy, and whether continued support is still useful.
5-Amino-1MQ is typically used as a metabolic-support compound. Taking time off after a focused cycle helps you reassess body-composition response, appetite changes, energy, and whether continued support is still useful.
Best Ways to Structure It
Option 14–8 weeks on, 2–4 weeks off
Best standard structure for general metabolic-support phases
Option 2Use during a cut phase
Then take time off once the fat-loss phase ends
Option 3Shorter trial phase
Useful when assessing individual response before committing to a longer cycle
When to Stop Sooner
No noticeable body-composition change is occurring
Energy or appetite response feels unfavorable
You are continuing without a clear goal or support phase
Monitoring During Use
Body composition changes
Energy levels
Appetite changes
Weight trends
Benefits
Supports fat metabolism
Targets NNMT pathway
May improve metabolic efficiency
Non-hormonal mechanism
Potential Side Effects
Mild fatigue during the initial phase
Appetite changes
Limited long-term human data
Variable individual response
Important Notes
Not a stimulant
Does not suppress appetite directly like GLP-1s
Often stacked with lifestyle interventions
Works through metabolic pathways, not hormones
Important Disclaimer
5-Amino-1MQ is an investigational compound and is not FDA-approved. This content is for educational purposes only.
Comments
Post a Comment